The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 08, 2020

Filed:

Jul. 27, 2020
Applicant:

Chimera Bioengineering, Inc., Menlo Park, CA (US);

Inventors:

Benjamin Wang, Menlo Park, CA (US);

Gusti Zeiner, Pacifica, CA (US);

Assignee:

Chimera Bioengineering, Inc., Menlo Park, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/63 (2006.01); C12N 9/02 (2006.01); C12N 9/96 (2006.01); C12Q 1/6897 (2018.01); C12Q 1/68 (2018.01);
U.S. Cl.
CPC ...
C12N 15/635 (2013.01); C12N 9/0008 (2013.01); C12N 9/96 (2013.01); C12N 15/63 (2013.01); C12Q 1/6897 (2013.01); C12Y 102/01012 (2013.01);
Abstract

Control Devices are disclosed including RNA destabilizing elements (RDE), RNA control devices, and destabilizing elements (DE) combined with Chimeric Antigen Receptors (CARs) or other transgenes in eukaryotic cells. Multicistronic vectors are also disclosed for use in engineering host eukaryotic cells with the CARs and transgenes under the control of the control devices. These control devices can be used to optimize expression of CARs in the eukaryotic cells so that, for example, effector function is optimized. CARs and transgene payloads can also be engineered into eukaryotic cells so that the transgene payload is expressed and delivered after stimulation of the CAR on the eukaryotic cell.


Find Patent Forward Citations

Loading…